AVEO Pharmaceuticals, Inc (AVEO) Covered Calls

AVEO Pharmaceuticals, Inc covered calls AVEO Pharmaceuticals Inc is a biopharmaceutical company, focused on discovering, developing and commercializing novel cancer therapeutics.

You can sell covered calls on AVEO Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AVEO (prices last updated Thu 1:25 PM ET):

AVEO Pharmaceuticals, Inc (AVEO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.99 -0.07 1.99 2.00 751K - 0.0B
Covered Calls For AVEO Pharmaceuticals, Inc (AVEO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 2 0.10 1.90 5.3% 215%
Jan 18 2 0.25 1.75 14.3% 141%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which is discovering, developing and commercializing targeted therapies to treat patients with cancer. Its proprietary human response platform provides the company unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates. The company's product candidates include AV-203, ficlatuzumab, tivozanib and AV-380. AVEO Pharmaceuticals was founded by Ronald A. DePinho, Lynda Chin and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.